No abstract available
MeSH terms
-
Anticarcinogenic Agents / therapeutic use*
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Breast Neoplasms / mortality
-
Breast Neoplasms / prevention & control*
-
Clinical Trials as Topic
-
Estrogen Antagonists / therapeutic use*
-
Female
-
Humans
-
Incidence
-
Survival Analysis
-
Tamoxifen / therapeutic use*
-
Treatment Outcome
-
United States / epidemiology
Substances
-
Anticarcinogenic Agents
-
Antineoplastic Agents, Hormonal
-
Estrogen Antagonists
-
Tamoxifen